{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:18Z","timestamp":1791910098118,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02427-1","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:58:38Z","timestamp":1783990718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gender-wise distribution of metabolic risk factors and their relationship with fibroblast growth factor 1 and gene polymorphism (rs152524)"],"prefix":"10.1186","volume":"19","author":[{"given":"Saima Naz","family":"Mohsin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambreen","family":"Muddassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Humayun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2427_CR1","unstructured":"World Health Organization. Key facts of Noncommunicable diseases (World Health Organization. September 2023). Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases. Accessed on 20th September 2024."},{"key":"2427_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/jehp.jehp_1113_22","volume":"12","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Kosalram K. The burden of non-communicable diseases: A scoping review focus on the context of India. J Educ Health Promot. 2023;12:41. https:\/\/doi.org\/10.4103\/jehp.jehp_1113_22 . PMID: 37113407; PMCID: PMC10127498.","journal-title":"J Educ Health Promot"},{"issue":"3","key":"2427_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/jfmpc.jfmpc_111_17","volume":"7","author":"R Panda","year":"2018","unstructured":"Panda R, Mahapatra S, Persai D. Health system preparedness in noncommunicable diseases: findings from two states Odisha and Kerala in India. J Family Med Prim Care. 2018;7(3):565\u201370.https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_111_17.","journal-title":"J Family Med Prim Care"},{"key":"2427_CR4","doi-asserted-by":"publisher","unstructured":"Kazmi T, Nagi M, Razzaq S, Hussnain S, Shahid N, Athar U. Burden of noncommunicable diseases in Pakistan. East Mediterr Health J. 2022;28(11):798\u2013804. https:\/\/doi.org\/10.26719\/emhj.22.083. PMID: 36515443.","DOI":"10.26719\/emhj.22.083"},{"issue":"6","key":"2427_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s42255-022-00580-2","volume":"4","author":"E Gasser","year":"2022","unstructured":"Gasser E, Sancar G, Downes M, Evans RM. Metabolic Messengers: fibroblast growth factor 1. Nat Metab. 2022;4(6):663\u201371. https:\/\/doi.org\/10.1038\/s42255-022-00580-2 . Epub 2022 Jun 9. PMID: 35681108; PMCID: PMC9624216.","journal-title":"Nat Metab"},{"issue":"2","key":"2427_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.52547\/wjps.10.2.76","volume":"10","author":"H Akbari","year":"2021","unstructured":"Akbari H, Ahmadi M, Fatemi MJ, Foroutan A, Akbari P, Bagheri H, Golkar M. The Role of Recombinant Fibroblast Growth Factor 1 in Enhancing the Angiogenesis in Random Cutaneous Flaps in Animal Model of Rat. World J Plast Surg. 2021;10(2):76\u201381. PMID: 34307101; PMCID: PMC8290444.","journal-title":"World J Plast Surg"},{"issue":"6","key":"2427_CR7","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/MCB.00940-13","volume":"34","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Chen KW, Chen CJ, Lin MH, Sun YJ, Lee JL, Chiu IM, Chen L. SH2B1\u03b2 interacts with STAT3 and enhances fibroblast growth factor 1-induced gene expression during neuronal differentiation. Mol Cell Biol. 2014;34(6):1003\u201319. https:\/\/doi.org\/10.1128\/MCB.00940-13 . Epub 2014 Jan 6. PMID: 24396070; PMCID: PMC3958036.","journal-title":"Mol Cell Biol"},{"issue":"42","key":"2427_CR8","doi-asserted-by":"publisher","first-page":"15546","DOI":"10.1073\/pnas.0607382103","volume":"103","author":"FB Engel","year":"2006","unstructured":"Engel FB, Hsieh PC, Lee RT, Keating MT. FGF1\/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci U S A. 2006;103(42):15546\u201351. https:\/\/doi.org\/10.1073\/pnas.0607382103 . Epub 2006 Oct 10. PMID: 17032753; PMCID: PMC1622860.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2427_CR9","doi-asserted-by":"publisher","first-page":"1198311","DOI":"10.3389\/fendo.2023.1198311","volume":"14","author":"JY Kim","year":"2023","unstructured":"Kim JY, Choi J, Kwon Y, Park S, Kim SG, Kim NH. Serum fibroblast growth factor 1 and its association with pancreatic beta cell function and insulin sensitivity in adults with glucose intolerance. Front Endocrinol (Lausanne). 2023;14:1198311. https:\/\/doi.org\/10.3389\/fendo.2023.1198311 . PMID: 37284218; PMCID: PMC10239951.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2427_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.EJ15-0627","volume":"63","author":"S Wang","year":"2016","unstructured":"Wang S, Yang Q, Yu S, Pan R, Jiang D, Liu Y, Hu H, Sun W, Hong X, Xue H, Qian W, Wang D, Zhou L, Mao C, Yuan G. Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls. Endocr J. 2016;63(4):359\u201365. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0627 . Epub 2016 Jan 21. PMID: 26806193.","journal-title":"Endocr J"},{"issue":"12","key":"2427_CR11","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1681\/ASN.2014121211","volume":"26","author":"M Tomaszewski","year":"2015","unstructured":"Tomaszewski M, Eales J, Denniff M, Myers S, Chew GS, Nelson CP, Christofidou P, Desai A, B\u00fcsst C, Wojnar L, Musialik K, Jozwiak J, Debiec R, Dominiczak AF, Navis G, van Gilst WH, van der Harst P, Samani NJ, Harrap S, Bogdanski P, Zukowska-Szczechowska E, Charchar FJ. Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure. J Am Soc Nephrol. 2015;26(12):3151\u201360. https:\/\/doi.org\/10.1681\/ASN.2014121211 . Epub 2015 Apr 27. PMID: 25918036; PMCID: PMC4657842.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2427_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.26719\/2018.24.1.33","volume":"24","author":"I Rafique","year":"2018","unstructured":"Rafique I, Saqib MAN, Munir MA, Qureshi H, Rizwanullah, Khan SA, et al. Prevalence of risk factors for noncommunicable diseases in adults: key findings from the Pakistan STEPS survey. East Mediterr Health J. 2018;24(1):33\u201341. https:\/\/doi.org\/10.26719\/2018.24.1.33.","journal-title":"East Mediterr Health J"},{"issue":"4","key":"2427_CR13","first-page":"50","volume":"116","author":"C Best","year":"2020","unstructured":"Best C, Shepherd E. Accurate measurement of weight and height 1: weighing patients. Nurs Times [online]. 2020;116(4):50\u20132.","journal-title":"Nurs Times [online]"},{"key":"2427_CR14","unstructured":"Warrier V, Krishan K, Shedge R et al. Height Assessment. [Updated 2023 Jul 25]. In: StatPearls . Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551524\/. Accessed on 29th September 2024."},{"key":"2427_CR15","doi-asserted-by":"publisher","unstructured":"Riaz M, Lodhi S. Beyond BMI: Exploring obesity trends in the south Asian region. Obes Pillars. 2024;13:100156. https:\/\/doi.org\/10.1016\/j.obpill.2024.100156. PMID: 39810860; PMCID: PMC11732094.","DOI":"10.1016\/j.obpill.2024.100156"},{"key":"2427_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40885-023-00252-7","volume":"29","author":"HL Kim","year":"2023","unstructured":"Kim HL, Park SM, Cho IJ, et al. Standardized protocol of blood pressure measurement and quality control program for the Korea National Health and Nutrition Examination Survey. Clin Hypertens. 2023;29:28. https:\/\/doi.org\/10.1186\/s40885-023-00252-7.","journal-title":"Clin Hypertens"},{"key":"2427_CR17","doi-asserted-by":"publisher","unstructured":"Zaid M, Hasnain S. Plasma lipid abnormalities in Pakistani population: trends, associated factors, and clinical implications. Braz J Med Biol Res. 2018;51(9). https:\/\/doi.org\/10.1590\/1414-431X20187239.","DOI":"10.1590\/1414-431X20187239"},{"key":"2427_CR18","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u2013421.","journal-title":"Circulation"},{"issue":"3","key":"2427_CR19","first-page":"229","volume":"32","author":"F Guan","year":"2014","unstructured":"Guan F, Shi G, Wan P, Dai R, Tang H, Wang H, Luo Y. Development of cost-effective tetra-ARMS PCR for detection of FecB genotype in sheep. Anim Sci Papers Rep. 2014;32(3):229\u201337.","journal-title":"Anim Sci Papers Rep"},{"key":"2427_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1875036201206010055","volume":"6","author":"A Collins","year":"2012","unstructured":"Collins A, Ke X. Primer1: Primer design web service for tetra-primer ARMS-PCR. Open Bioinf J. 2012;6:55\u20138.","journal-title":"Open Bioinf J"},{"key":"2427_CR21","doi-asserted-by":"publisher","first-page":"113498","DOI":"10.1016\/j.ygcen.2020.113498","volume":"294","author":"PA Kolodziejski","year":"2020","unstructured":"Kolodziejski PA, Sassek M, Bien J, Leciejewska N, Szczepankiewicz D, Szczepaniak B, et al. FGF-1 modulates pancreatic \u03b2-cell functions\/metabolism: An in vitro study. Gen Comp Endocrinol. 2020;294:113498.","journal-title":"Gen Comp Endocrinol"},{"key":"2427_CR22","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1210\/jc.2009-2049","volume":"95","author":"N Mejhert","year":"2010","unstructured":"Mejhert N, Galitzky J, Pettersson AT, Bambace C, Blomqvist L, et al. Mapping of the fibroblast growth factors in human white adipose tissue. J Clin Endocrinol Metab. 2010;95:2451\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2427_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13058-023-01699-0","volume":"25","author":"M Castillo-Castrejon","year":"2023","unstructured":"Castillo-Castrejon M, Sankofi BM, Murguia SJ, et al. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer. Breast Cancer Res. 2023;25:99. https:\/\/doi.org\/10.1186\/s13058-023-01699-0.","journal-title":"Breast Cancer Res"},{"key":"2427_CR24","doi-asserted-by":"publisher","first-page":"1406951","DOI":"10.3389\/fonc.2024.1406951","volume":"14","author":"A Marin","year":"2024","unstructured":"Marin A, Morales F, Walbaum B. Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance. Front Oncol. 2024;14:1406951. https:\/\/doi.org\/10.3389\/fonc.2024.1406951.","journal-title":"Front Oncol"},{"key":"2427_CR25","doi-asserted-by":"publisher","unstructured":"El Yazidi I, Renaud F, Laurent M, Courtois Y, Boilly-Marer Y. Production and oestrogen regulation of FGF1 in normal and cancer breast cells. Biochim Biophys Acta. 1998;1403(2):127\u2009\u2013\u200940. https:\/\/doi.org\/10.1016\/s0167-4889(98)00033-0. PMID: 9630568.","DOI":"10.1016\/s0167-4889(98)00033-0"},{"issue":"2","key":"2427_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","volume":"49","author":"KM Gavin","year":"2020","unstructured":"Gavin KM, Bessesen DH. Sex Differences in Adipose Tissue Function. Endocrinol Metab Clin North Am. 2020;49(2):215\u201328. https:\/\/doi.org\/10.1016\/j.ecl.2020.02.008 . Epub 2020 Apr 16. PMID: 32418585; PMCID: PMC7921847.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2427_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1530\/ec-18-0141","volume":"7","author":"A Wang","year":"2018","unstructured":"Wang A, Yan X, Zhang C, Du C, Long W, Zhan D, et al. Characterization of fibroblast growth factor 1 in obese children and adolescents. Endocr Connect. 2018;7:932\u201340. https:\/\/doi.org\/10.1530\/ec-18-0141.","journal-title":"Endocr Connect"},{"key":"2427_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0043-104532","volume":"125","author":"J Zhu","year":"2017","unstructured":"Zhu J, Wang Y, Zhu K, Gao J, Wan X, Pang X, et al. Serum fibroblast growth factor 1 is associated with the decreased risk of obesity in human. Exp Clin Endocrinol Diabetes. 2017;125:322\u20136. https:\/\/doi.org\/10.1055\/s-0043-104532.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2427_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature10998","volume":"485","author":"JW Jonker","year":"2012","unstructured":"Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, et al. A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature. 2012;485:391\u20134. https:\/\/doi.org\/10.1038\/nature10998.","journal-title":"Nature"},{"key":"2427_CR30","doi-asserted-by":"crossref","unstructured":"Wang J, Zhang F, Yang W, Gao D, Yang L, Yu C, Chen C, Li X, Zhang J-S. FGF1 ameliorates obesity-associated hepatic steatosis by reversing IGFBP2 hypermethylation. FASEB J. April 2023;37(Issue4):e22881.","DOI":"10.1096\/fj.202201950R"},{"issue":"1","key":"2427_CR31","doi-asserted-by":"publisher","first-page":"20180063","DOI":"10.1515\/hmbci-2018-0063","volume":"38","author":"G Saber","year":"2019","unstructured":"Saber G, Kasabri V, Saleh M, Suyagh M, Halaseh L, Jaber R, Abu-Hassan H, Alalawi S. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes. Horm Mol Biol Clin Investig. 2019;38(1):20180063. https:\/\/doi.org\/10.1515\/hmbci-2018-0063.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2427_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fendo.2015.00193","volume":"6","author":"VJ Nies","year":"2016","unstructured":"Nies VJ, Sancar G, Liu W, et al. Fibroblast growth factor signaling in metabolic regulation. Front Endocrinol (Lausanne). 2016;6:193.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2427_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.021","volume":"53","author":"KR Markan","year":"2016","unstructured":"Markan KR, Potthoff MJ. Metabolic fibroblast growth factors (FGFs): mediators of energy homeostasis. Semin Cell Dev Biol. 2016;53:85\u201393.","journal-title":"Semin Cell Dev Biol"},{"key":"2427_CR34","doi-asserted-by":"crossref","unstructured":"Tomaszewski M. Evidence for associations between fibroblast growth factor 1 gene and human hypertension. Endocr Abstracts. 13. 2007.","DOI":"10.1161\/CIRCULATIONAHA.107.710293"},{"key":"2427_CR35","volume-title":"10 Mar","author":"L Phan","year":"2020","unstructured":"Phan L, Jin Y, Zhang H, Qiang W, Shekhtman E, Shao D, Revoe D, Villamarin R, Ivanchenko E, Kimura M, Wang ZY, Hao L, Sharopova N, Bihan M, Sturcke A, Lee M, Popova N, Wu W, Bastiani C, Ward M, Holmes JB, Lyoshin V, Kaur K, Moyer E, Feolo M, Kattman BL. 10 Mar. ALFA: Allele Frequency Aggregator. National Center for Biotechnology Information, U.S. National Library of Medicine; 2020. www.ncbi.nlm.nih.gov\/snp\/docs\/gsr\/alfa\/."},{"key":"2427_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1101\/gr.9.8.677","volume":"9","author":"ST Sherry","year":"1999","unstructured":"Sherry ST, Ward M, Sirotkin K. dbSNP\u2014Database for Single Nucleotide Polymorphisms and Other Classes of Minor Genetic Variation. Genome Res. 1999;9:677\u20139.","journal-title":"Genome Res"},{"key":"2427_CR37","unstructured":"dbSNP- Database for Single Nucleotide Polymorphisms. (rs152524) available on https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs152524#frequency_tab. accessed\/cited on 10th October 2024."},{"key":"2427_CR38","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.107.710293","volume":"116","author":"M Tomaszewski","year":"2007","unstructured":"Tomaszewski M, Charchar FJ, Lynch MD, Padmanabhan S, Wang WY, Miller WH, Grzeszczak W, Maric C, Zukowska-Szczechowska E, Dominiczak AF. Fibroblast growth factor 1 gene and hypertension: From the quantitative trait locus to positional analysis. Circulation. 2007;116:1915\u201324.","journal-title":"Circulation"},{"issue":"5","key":"2427_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1681\/ASN.2010080829","volume":"22","author":"M Tomaszewski","year":"2011","unstructured":"Tomaszewski M, Charchar FJ, Nelson CP, Barnes T, Denniff M, Kaiser M, Debiec R, Christofidou P, Rafelt S, van der Harst P, Wang WY, Maric C, Zukowska-Szczechowska E, Samani NJ. Pathway analysis shows association between FGFBP1 and hypertension. J Am Soc Nephrol. 2011;22(5):947\u201355. Epub 2011 Mar 24. PMID: 21436287; PMCID: PMC3083316.","journal-title":"J Am Soc Nephrol"},{"key":"2427_CR40","doi-asserted-by":"publisher","first-page":"e11545","DOI":"10.1371\/journal.pone.0011545","volume":"5","author":"MT Lindenmeyer","year":"2010","unstructured":"Lindenmeyer MT, Eichinger F, Sen K, Anders HJ, Edenhofer I, Mattinzoli D, Kretzler M, Rastaldi MP, Cohen CD. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset. PLoS ONE. 2010;5:e11545.","journal-title":"PLoS ONE"},{"key":"2427_CR41","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1073\/pnas.2234604100","volume":"100","author":"D Chabard\u00e8s-Garonne","year":"2003","unstructured":"Chabard\u00e8s-Garonne D, Mej\u00e9an A, Aude JC, Cheval L, Di Stefano A, Gaillard MC, Imbert-Teboul M, Wittner M, Balian C, Anthouard V, Robert C, S\u00e9gurens B, Wincker P, Weissenbach J, Doucet A, Elalouf JM. A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci. 2003;100:13710\u20135.","journal-title":"Proc Natl Acad Sci"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02427-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:03:47Z","timestamp":1791907427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02427-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2427"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02427-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Helsinki Declarations were followed in the conduct of all study methodologies and procedures. The Technical and Ethical Review Committee, Shaikh Zayed Medical Complex, Lahore, approved this study (protocol number: TERC\/SC\/EXT\/2023\/208) In order to be eligible to take part in this study, each participant gave their written informed consent. Patient data was kept confidential for the entire study duration.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"154"}}